Phathom Pharmaceuticals, Inc.
PHAT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001783183
No open-market purchases or sales by Phathom Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $782.1M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Phathom Pharmaceuticals, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 103 | 1 | 110 | +8 |
| Shares | 42.8M | 140 | 43.8M | +981.6K (+2.3%) |
| Value | $612.6M | $2.00K | $452.7M | −$159.9M (−26.1%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Phathom Pharmaceuticals, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Algert Global LLC | 91,820 | $952.2K | 0.04% |
| Walleye Capital LLC | 85,372 | $885.3K | 0.01% |
| Schonfeld Strategic Advisors LLC | 38,744 | $401.8K | 0.00% |
| AQR Capital Management LLC | 22,835 | $236.8K | 0.00% |
| Squarepoint Ops LLC | 18,815 | $195.1K | 0.00% |
| ExodusPoint Capital Management, LP | 17,008 | $176.0K | 0.00% |
| XTX Topco Ltd | 14,847 | $154.0K | 0.03% |
| Engineers Gate Manager LP | 12,888 | $133.6K | 0.00% |
| SG Americas Securities, LLC | 12,164 | $126.0K | 0.00% |
| Ameriprise Financial Inc | 11,402 | $118.2K | 0.00% |
| Centiva Capital, LP | 10,962 | $113.7K | 0.01% |
| Public Employees Retirement System of Ohio | 8,900 | $92.0K | 0.00% |
| Headinvest, LLC | 882 | $8.95K | 0.00% |
| The PNC Financial Services Group, Inc. | 130 | $1.35K | 0.00% |
| ZRC Wealth Management, LLC | 20 | $208 | 0.00% |
Sold out (7)
Institutions that held Phathom Pharmaceuticals, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 656,000 | $9.39M |
| Tang Capital Management LLC | 250,000 | $3.58M |
| Silverarc Capital Management, LLC | 200,000 | $2.86M |
| Susquehanna International Group, LLP | 63,408 | $908.0K |
| Atom Investors LP | 53,286 | $763.1K |
| Ergoteles LLC | 18,300 | $262.1K |
| Renaissance Technologies LLC | 10,000 | $143.0K |
Not filed for Q3 2023 yet (1)
Institutions that held Phathom Pharmaceuticals, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| BerganKDV Wealth Management, LLC | 140 | $2.00K |